Virpax Pharmaceuticals, Inc.
Probudur, a liposomal-encapsulated local anesthetic for sustained post-operative pain management
- Sector
- Medtech
- Headquarters
- BERWYN, PA
- Founded
- 2017
- Latest Form D
- $2.5M, Jul 2024
- Total capital
- $3.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.9M
- 2 Form D · last Jul 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$2.5M
- Private capital raisedForm D · SEC · 1st filing$1.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Anthony MackExecutive Officer, DirectorNamed in SEC Form D filings
- Eric FloydDirectorNamed in SEC Form D filings
- Gary M. HermanDirectorNamed in SEC Form D filings
- Gerald BruceExecutive Officer, DirectorNamed in SEC Form D filings
- Jatinder M. DhaliwalDirectorNamed in SEC Form D filings
- Jeffrey GudinExecutive Officer, DirectorNamed in SEC Form D filings
Show all 13 people
- Jerrold SendrowDirectorNamed in SEC Form D filings
- Judy M. SuDirectorNamed in SEC Form D filings
- Katharyn M. FieldDirectorNamed in SEC Form D filings
- Sheila M. MathiasExecutive OfficerNamed in SEC Form D filings
- Thani JambulingamDirectorNamed in SEC Form D filings
- Vanila M. SinghDirectorNamed in SEC Form D filings
- Vinay ShahExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingNsaid Spray Formulation And MethodUSPTOApplication PCTUS2024041405
- PendingIntranasal DeliveryUSPTOApplication PCTUS2024036371
- PendingNSAID Spray Formulation and MethodUSPTOApplication 63531595
Show all 5 patent records
- Nsaid Spray Formulation And MethodApplication PCTUS2024041405Pending
- Intranasal DeliveryApplication PCTUS2024036371Pending
- NSAID Spray Formulation and MethodApplication 63531595Pending
- Intranasal DeliveryApplication 63524764Pending
- Nsaid Spray Formulation And MethodApplication 19506746Pending
Related companies, and why
- ADVANCED IMAGING RESEARCH, INC.Similar federal contract value in Medtech · null in contracts
- CLEAR GENE INCSimilar federal contract value in Medtech · null in contracts
- Micron Pure, LLCSimilar federal contract value in Medtech · null in contracts
- INLIGHTA BIOSCIENCES, LLCSimilar federal contract value in Medtech · null in contracts
- Anelleo, Inc.Similar federal contract value in Medtech · null in contracts
- Fresenius Medical Care East Brunswick, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .